ondansetron

(redirected from Ondansetron hydrochloride)
Also found in: Medical.

on·dan·se·tron

 (ŏn-dăn′sĭ-trŏn′)
n.
A selective serotonin receptor antagonist, C18H19N3O, used in its hydrochloride form to prevent nausea and vomiting, especially when occurring postoperatively or as a result of chemotherapy or radiotherapy.

[ondan-, of unknown origin + -setron (from (se(ro)t(onin) r(eceptor antag)on(ist)).]
Translations

ondansetron

n ondansetrón m
References in periodicals archive ?
Ondansetron hydrochloride was obtained from Cipla Limited, Mumbai, India.
2) Here we present a rare case of FDE following the intake of ondansetron hydrochloride.
Contract awarded for moh 2016-roo-cd-0318 (acquisition aspirin 100mg / simvastatin 40mz / 5-10 ramipril caps; ondansetron hydrochloride tablet and etoposide)
Determination of ondansetron hydrochloride by a liquid membrane potentiometric sensor based on room temperature ionic liquids.
The patients were randomized to receive orally either 8mg of Ondansetron hydrochloride dehydrate (Zofer-Natco) or identical looking placebo tablets.
has received approval for ondansetron hydrochloride injection USP, 2 mg/mL.
South San Francisco, CA) has licensed exclusive United States and Canadian rights to a proprietary lingual spray formulation of the anti-emetic compound ondansetron hydrochloride, the active ingredient of GlaxoSmithkline's Zofran .
Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for Ondansetron Hydrochloride Injection USP, 2 mg/mL ("Ondansetron Injection").
10) demonstrated that a patient with HIV infection presented with repeated vomiting and chronic diarrhea unresponsive to medications, including metronidazole, azithromycin, ondansetron hydrochloride, and intravenous octreotide.
Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Applications (ANDA) to market Ondansetron Hydrochloride Tablets, 4 mg, 8 mg and 24 mg and Ondansetron Orally Disintegrating Tablets USP, 4 mg and 8 mg.
subsidiary to manufacture ondansetron hydrochloride orally disintegrating tablets in 4- and 8-mg strengths.
Ondansetron hydrochloride is the active ingredient in Zofran[R], GlaxoSmithKline's tablet and injection formulations to prevent chemotherapy and radiation related nausea and vomiting.